Paper6402
Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution.
Katz IM and 3 others. Invest Ophthalmol, 1976. Cited by 231 papers, by iCite.
Cite this record
ConductScience Library. Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution. Papers, record 6402. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6402
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic beta-Antagonists | Major topic |
| Adult | |
| Blood Pressure | |
| Depression, Chemical | |
| Female | |
| Humans | |
| Intraocular Pressure | |
| Male | |
| Middle Aged | |
| Ophthalmic Solutions | |
| Placebos | |
| Pulse | |
| Pupil | |
| Time Factors | |
| Visual Acuity |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41471311 | Challenge of Corneal Ulcer Healing: A Novel Conceptual Framework, the "Triad" of Corneal Ulcer Healing/Corneal Neovascularization/Intraocular Pressure, and Avascular Tendon Healing, for Evaluation of Corneal Ulcer Therapy, Therapy of Neovascularization, Glaucoma Therapy, and Pentadecapeptide BPC 157 Efficacy. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41471311 | PubMed |
| 34421514 | Inhibitory and Agonistic Autoantibodies Directed Against the β2-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma. | Front Neurosci | 2021 | https://conductscience.org/library/papers/34421514 | PubMed |
| 33237496 | Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events. | Am J Clin Dermatol | 2021 | https://conductscience.org/library/papers/33237496 | PubMed |
| 32012756 | 17β-Estradiol Delivered in Eye Drops: Evidence of Impact on Protein Networks and Associated Biological Processes in the Rat Retina through Quantitative Proteomics. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32012756 | PubMed |
| 30794789 | Effect of Timolol on Aqueous Humor Outflow Facility in Healthy Human Eyes. | Am J Ophthalmol | 2019 | https://conductscience.org/library/papers/30794789 | PubMed |
| 29483909 | Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma. | Front Immunol | 2018 | https://conductscience.org/library/papers/29483909 | PubMed |
| 27916026 | Role of cyclic AMP in the eye with glaucoma. | BMB Rep | 2017 | https://conductscience.org/library/papers/27916026 | PubMed |
| 27622679 | Quadrant Field Pupillometry Detects Melanopsin Dysfunction in Glaucoma Suspects and Early Glaucoma. | Sci Rep | 2016 | https://conductscience.org/library/papers/27622679 | PubMed |
| 27471373 | The intraocular pressure-lowering properties of intravenous paracetamol. | Clin Ophthalmol | 2016 | https://conductscience.org/library/papers/27471373 | PubMed |
| 27041984 | Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenon. | Clin Ophthalmol | 2016 | https://conductscience.org/library/papers/27041984 | PubMed |
| 26356532 | Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions. | J Med Chem | 2016 | https://conductscience.org/library/papers/26356532 | PubMed |
| 24550667 | Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension. | Clin Ophthalmol | 2014 | https://conductscience.org/library/papers/24550667 | PubMed |
| 24313227 | Mechanism and site of inhibition of AMPA receptors: pairing a thiadiazole with a 2,3-benzodiazepine scaffold. | ACS Chem Neurosci | 2014 | https://conductscience.org/library/papers/24313227 | PubMed |
| 12386095 | Myopia: attempts to arrest progression. | Br J Ophthalmol | 2002 | https://conductscience.org/library/papers/12386095 | PubMed |
| 11196122 | A comparative study on the effects of apraclonidine and timolol on the ophthalmic blood flow velocity waveforms. | Int Ophthalmol | 1999 | https://conductscience.org/library/papers/11196122 | PubMed |
| 7952875 | Role of cyclic AMP-induced Cl conductance in aqueous humour formation by the dog ciliary epithelium. | Br J Pharmacol | 1994 | https://conductscience.org/library/papers/7952875 | PubMed |
| 7387959 | Timolol in operated closed-angle glaucoma. | Br J Ophthalmol | 1980 | https://conductscience.org/library/papers/7387959 | PubMed |
| 7257075 | Epinephrine distribution after topical administration to phakic and aphakic eyes. | Trans Am Ophthalmol Soc | 1980 | https://conductscience.org/library/papers/7257075 | PubMed |
| 7216626 | Effects of timolol on corneal sensitivity and tear production. | Int Ophthalmol | 1980 | https://conductscience.org/library/papers/7216626 | PubMed |
| 7075965 | The IOP-lowering effect of timolol in simple and capsular glaucoma. A multicenter study in Finland. | Graefes Arch Clin Exp Ophthalmol | 1982 | https://conductscience.org/library/papers/7075965 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6402
GET https://conductscience.org/api/papers/v1/6402/cited_by?page=2